Answers are grounded in this paper and cite their sources.
Surgical procedures that lower portal pressure, such as portacaval shunts, prevent variceal hemorrhage. Portal hypertension is the result of increased flow and increased resistance in the portal system. Pharmacologic therapy is aimed at altering these factors by the use of vasoconstrictors to reduce flow and vasodilators to decrease resistance. The current status of pharmacologic agents to achieve these effects is reviewed.
No takes yet. Share an insight, caveat, or question.
Groszmann et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: